跳至主要内容
临床试验/TCTR20230206002
TCTR20230206002已完成不适用

The use of ROX index to predict failure of high-flow nasal cannula in patients with COVID-19 associated acute respiratory distress syndrome.

The Research Fund of the Faculty of Medicine Vajira Hospital0 个研究点目标入组 212 人开始时间: 2023年2月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
212

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 85 Years(—)
性别
All

入选标准

  • 1. Patients aged 18 or older.
  • 2. Patients with confirmed diagnosis of COVID-19 infection using a positive for reverse transcription polymerase chain reaction (RT-PCR)
  • 3. Bilateral infiltration in chest radiography
  • 4. Started HFNC therapy during hospitalization.

排除标准

  • 1. Patients who initiated IMV before commencing HFNC therapy.
  • 2. Patients with signed a do-not-resuscitate advance medical directive.
  • 3. Patients who transferred to another hospital during HFNC therapy.

研究者

发起方
The Research Fund of the Faculty of Medicine Vajira Hospital

相似试验